Advertisement
Letter to the Editor| Volume 118, P52-53, May 2022

Authors’ response to Dr Finsterer's comment “Exclude differentials before diagnosing SARS-CoV-2-associated acute hemorrhagic necrotizing encephalitis” (THEIJID-D-22-00008)

Open AccessPublished:February 09, 2022DOI:https://doi.org/10.1016/j.ijid.2022.02.014
      Sir,
      We thank Dr Finsterer for his interest in our publication.
      Considering his remark that we did not consider the acute necrotizing encephalopathy (ANE) case by Lazarte-Rantes, we did cite it (
      • Lazarte-Rantes C
      • Guevara-Castañón J
      • Romero L
      • Guillén-Pinto D
      Acute Necrotizing Encephalopathy Associated With SARS-CoV-2 Exposure in a Pediatric Patient.
      ). We discussed the inconsistencies in the literature regarding the diagnosis of acute necrotizing hemorrhagic encephalitis (AHNE) and ANE. The cases seem different because our patient was SARS-CoV-2 polymerase chain reaction (PCR)–positive, whereas Lazarte-Rantes's case was PCR-negative. The association with SARS-CoV-2 was only based on positive IgG; IgM was negative. This suggests a past SARS-CoV-2 infection in previous months. No genetic testing was done and ANE may result from genetic mutations. Therefore, SARS-CoV-2 might not have been the cause of ANE in their case, especially because seropositivity is common during the COVID-19 pandemic (
      • Lazarte-Rantes C
      • Guevara-Castañón J
      • Romero L
      • Guillén-Pinto D
      Acute Necrotizing Encephalopathy Associated With SARS-CoV-2 Exposure in a Pediatric Patient.
      ).
      We regret that Dr Finsterer had the idea that we underestimated the burden of pediatric COVID-19. We wrote that it was commonly benign because many children are asymptomatic and usually do not require hospitalization. In a recent study, the average duration of symptoms (most commonly headaches and fatigues) was 6 days (
      • Molteni E
      • Sudre CH
      • Canas LS
      • Bhopal SS
      • Hughes RC
      • Antonelli M
      • Murray B
      • Kläser K
      • Kerfoot E
      • Chen L
      • Deng J
      • Hu C
      • Selvachandran S
      • Read K
      • Capdevila Pujol J
      • Hammers A
      • Spector TD
      • Ourselin S
      • Steves CJ
      • Modat M
      • Absoud M
      • Duncan EL
      Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
      ). We emphasized that severe cases existed. We mentioned other severe neurologic manifestations; however, we did not discuss all the COVID-19 complications, as it was not the topic of our article.
      Concerning diagnostics, the tests included HSV1, 2, HHV6, VZV, EBV, CMV, adenovirus, coronavirus 229E, HKU1, NL63, OC43, MERS-CoV, human metapneumovirus, human rhino/enterovirus, Influenza A, A/H1, A/H1-2009, A/H3, B, Parainfluenza 1, 2, 3, 4, RSV, Bordatella parapertussis, Chlamydia, Mycoplasma pneumoniae, and bacteria. We did not include tuberculosis (TB) in differentials, as it is extremely rare in our country in patients at this age. There were 39 cases of TB in patients aged <14 years in Poland in 2020; of those, 2 were cases of extrapulmonary TB, with no cases of meningitis (
      • Korzeniewska-Kosela M.
      Gruźlica i Choroby Układu Oddechowego w Polsce w 2020r. red. Maria Korzeniewska-Koseła.
      ). BCG vaccination of all neonates is mandatory in Poland. The only source of the infantile TB infection could be the parents, and they are healthy with no cases of TB in their family. They had limited contact with other people because of the pandemic.
      We agree that repeating a lumbar puncture would have been indicated. The fulminant progression to massive brain edema made it impossible. We performed all the most important diagnostic tests available. We could not confirm the SARS-CoV-2 in the cerebrospinal fluid (CSF). As we did not have a validated method to detect SARS-CoV-2 in the CSF, we used the standard PCR method for nasopharyngeal swabs. Possibly, its sensitivity was too low. Lewis et al. detected the viral presence of SARS-CoV-2 in CSF in 2 of 59 children and 17 of 303 of all COVID-19 patients with neurological manifestations (
      • Lewis A
      • Frontera F
      • Placantonakis DG
      • Lighter J
      • Galetta S
      • Balcer L
      • Melmed KR.
      Cerebrospinal fluid in COVID-19: A systematic review of the literature.
      ). Therefore, the absence of the virus in CSF does not exclude this etiology. We also agree that the autopsy would have been important. Unfortunately, we did not get consent for the procedure.

      Declaration of Competing Interest

      The authors declare no conflict of interest.

      Funding

      We did not receive any funding for this publication.

      Ethical Approval

      This publication complies with ethical standards. Ethical approval was requested from the Medical University of Warsaw Ethical Committee; however, it was judged as not required.

      Reference

        • Korzeniewska-Kosela M.
        Gruźlica i Choroby Układu Oddechowego w Polsce w 2020r. red. Maria Korzeniewska-Koseła.
        Instytut Gruzlicy i Chorob Pluc, Warszawa, 2021 (data from the Department of Epidemiology National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland (in polish))
        • Lazarte-Rantes C
        • Guevara-Castañón J
        • Romero L
        • Guillén-Pinto D
        Acute Necrotizing Encephalopathy Associated With SARS-CoV-2 Exposure in a Pediatric Patient.
        Cureus. 2021; 13: e15018https://doi.org/10.7759/cureus.15018
        • Lewis A
        • Frontera F
        • Placantonakis DG
        • Lighter J
        • Galetta S
        • Balcer L
        • Melmed KR.
        Cerebrospinal fluid in COVID-19: A systematic review of the literature.
        J Neurol Sci. 2021; 421 (Published online 2021 Jan 10)117316https://doi.org/10.1016/j.jns.2021.117316
        • Molteni E
        • Sudre CH
        • Canas LS
        • Bhopal SS
        • Hughes RC
        • Antonelli M
        • Murray B
        • Kläser K
        • Kerfoot E
        • Chen L
        • Deng J
        • Hu C
        • Selvachandran S
        • Read K
        • Capdevila Pujol J
        • Hammers A
        • Spector TD
        • Ourselin S
        • Steves CJ
        • Modat M
        • Absoud M
        • Duncan EL
        Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
        Lancet Child Adolesc Health. 2021; 5: 708-718https://doi.org/10.1016/S2352-4642(21)00198-X